Blog
Article
Author(s):
Strategic considerations and transaction trends
Interest remains robust for investment in the primary care space by private equity sponsors and other strategic partners. The proliferation of medical practice transactions involving a sale, merger, investment or other partnership overall has been increasing throughout the past decade, and primary care is at the top of the list for investors, especially in recent years.
The importance of primary care professionals — to manage a patient’s overall health, to reduce complications and to provide preventive care — is underscored by many factors, including the following:
These factors position primary care physicians more than ever at the epicenter of the future of medicine. Additionally, the shortage of primary care professionals, which had persisted in the industry for some time and has recently become more pronounced, translates to even higher demand for primary care providers.
Physicians make the decision to engage with strategic partners for a variety of reasons, often due to the circumstances related to reduced reimbursement for a particular specialty, desire for growth or to competition. The most frequently cited reasons are the financial impacts of decreasing reimbursements and increasing costs of private medical practice (including staff costs and costs of compliance with the multitude of privacy, security, billing and coding, notice, reporting and other regulations).
Perhaps one of the less publicized advantages for a primary care physician to enter into a strategic partnership is that many potential partners have seasoned, full-time executive management teams and trained personnel (e.g., human resources, information technology, compliance, billing and managed care executives) who can provide a C-suite infrastructure to practice most effectively, and to help guide the enterprise into the future while navigating future uncertainties (e.g., the next pandemic, recession, inflation, valued-based care).
Physicians should carefully consider their specific goals in entering a strategic transaction and determine the ability of prospective partners to help achieve those goals. For example, if becoming part of a larger organization and gaining access to financial resources for growth are the primary goals, but preserving clinical independence at the local level is essential, then physicians will want to explore with their prospective partners how the practice is expected to evolve after closing a transaction.
The right strategic partner should be able to offer advantageous experience in negotiating with payers, vendors and suppliers, and thus leverage economies of scale, and help providers better compete and attract new physicians.
For so many patients, having a primary care provider who understands their overall health profile, particular needs and even style and approach to managing illnesses or symptoms is vital, more so than in most other fields in health care. Therefore, optimal strategic partners for primary care physicians are likely those who can assist with effective community outreach and marketing, scheduling and other services to support the unique primary care-patient relationship.
The right strategic partner should also be able to increase the efficiency of delivering care, which would help to address the shortage of primary care providers and physician burnout, whether through implementing technology to assist with repetitive or administrative tasks (while enabling the physician to spend less time in front of a monitor or hand-held device), through physicians delegating aspects of operating the business of health care to a partner’s back office personnel, or helping to recruit new physicians and midlevel practitioners to fill current demand and future growth.
However, primary care physicians should assess not only the reasons causing them to consider a strategic partnership and their essential goals going into it, but also what life will be like once the transaction has closed. Key to the analysis of whether to undertake such a transaction is the ability of the strategic partner to execute on the business plan proposed in their preliminary discussions. Physicians should specifically look to a potential partner’s track record of past successes, the quality of the leadership team and the resources that will be available for implementing said plan.
For primary care physicians, due to the wide ranges in quality and availability across providers and regions, practitioners considering a strategic transaction should also consider the “bench” of other primary care providers that a potential partner has been able to assemble for the overall organization, in addition to the affiliation structure, as different models and types of partners have shown varying levels of success in the primary care setting. For example, some strategic partners will have implemented policies and procedures to emphasize an improved quality of care, including peer review and performance or incentive-based compensation.
For primary care providers not yet immersed in value-based care, a strategic partner may be able to help educate the practice’s owners and staff as to the benefits of, and assist with implementing and operating within, the optimal models for your practice — including through the use of advanced technology (electronic health records, data analytics) as well as the use of experienced care coordinators.
Primary care physicians now can choose from among a greater number of different types of strategic partners to consider for a transaction, ranging from the more traditional practice settings such as larger multispecialty groups and hospital systems to private equity-backed medical practice platforms, provider arms of insurance carriers and the latest newcomers to the field, the retail-based organizations such as CVS, Amazon, Walmart and Walgreens. Each type of partner has its own pros and cons, with of course additional distinctions among the players within a given category. As such, providers should conduct their own due diligence of a potential partner before entering into any agreements.
Fortunately, there are capable advisers available to help vet prospective partners as well as gauge the proposed business terms and legal features of competing partnership proposals—investment bankers, accountants, attorneys and consultants. We cannot stress enough how important it is to be well-educated and advised in entering a once-in-a-lifetime sale of the valuable medical practice that you built over many years with your blood, sweat and tears.
Although the cost of capital has increased in the last year, primarily due to rising interest rates, it has not yet had an overwhelming impact on the direction of the industry and the continuing consolidation in the health care space (and there are early indications of potential interest rate reductions later this year).
Gary W. Herschman and Conor F. Murphy are members of the health care and life sciences practice in the Newark and New York offices of Epstein Becker & Green P.C. The 2024 Physician Transactions Conference takes place Feb. 15, 2024, in San Francisco with additional information online.
2 Commerce Drive
Cranbury, NJ 08512